IN2014MN00949A - - Google Patents

Info

Publication number
IN2014MN00949A
IN2014MN00949A IN949MUN2014A IN2014MN00949A IN 2014MN00949 A IN2014MN00949 A IN 2014MN00949A IN 949MUN2014 A IN949MUN2014 A IN 949MUN2014A IN 2014MN00949 A IN2014MN00949 A IN 2014MN00949A
Authority
IN
India
Prior art keywords
interleukin
chain
relates
coagulation factor
factor xiii
Prior art date
Application number
Other languages
English (en)
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of IN2014MN00949A publication Critical patent/IN2014MN00949A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IN949MUN2014 2011-11-22 2012-11-20 IN2014MN00949A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201161562885P 2011-11-22 2011-11-22
US201161562943P 2011-11-22 2011-11-22
US201161562872P 2011-11-22 2011-11-22
US201161562813P 2011-11-22 2011-11-22
US201161562802P 2011-11-22 2011-11-22
US201161562879P 2011-11-22 2011-11-22
US201161562916P 2011-11-22 2011-11-22
US201161562951P 2011-11-22 2011-11-22
US201161562778P 2011-11-22 2011-11-22
US201161562947P 2011-11-22 2011-11-22
US201161562817P 2011-11-22 2011-11-22
US201161562829P 2011-11-22 2011-11-22
US201161562824P 2011-11-22 2011-11-22
US201161562883P 2011-11-22 2011-11-22
PCT/US2012/066152 WO2013078253A1 (en) 2011-11-22 2012-11-20 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
IN2014MN00949A true IN2014MN00949A (ja) 2015-04-24

Family

ID=48470273

Family Applications (1)

Application Number Title Priority Date Filing Date
IN949MUN2014 IN2014MN00949A (ja) 2011-11-22 2012-11-20

Country Status (6)

Country Link
US (2) US20140315752A1 (ja)
EP (2) EP2783213B1 (ja)
AU (1) AU2012340748A1 (ja)
CA (1) CA2856399A1 (ja)
IN (1) IN2014MN00949A (ja)
WO (1) WO2013078253A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150017671A1 (en) 2004-04-16 2015-01-15 Yaping Shou Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
EP3004873B1 (en) * 2013-06-05 2024-01-24 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2015073934A1 (en) * 2013-11-15 2015-05-21 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of sepsis
WO2016069925A1 (en) * 2014-10-30 2016-05-06 Acceleron Pharma Inc. Methods and compositions using gdf15 polypeptides for increasing red blood cells
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
CA3165653A1 (en) 2019-12-23 2021-07-01 Fundacio Institut D'investigacio En Ciencies De La Salut Germans Trias I Pujol (Igtp) New protein markers of renal damage

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
AU658374B2 (en) 1990-09-14 1995-04-13 Biosite Diagnostics Incorporated Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
WO1992018868A1 (en) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Crosstalk inhibitors and their uses
DE69231382T2 (de) 1991-04-12 2001-01-25 Biosite Diagnostics Inc Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
US20040009171A1 (en) * 2001-10-18 2004-01-15 Genentech, Inc. Methods for the treatment of carcinoma
US20090258002A1 (en) * 2005-02-01 2009-10-15 Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services Biomarkers for Tissue Status
EP2095107B1 (en) * 2006-11-14 2014-07-02 Alere San Diego, Inc. Methods for risk assignment
US8221995B2 (en) * 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US11150250B2 (en) * 2008-08-28 2021-10-19 Astute Medical, Inc. Methods for diagnosing acute kidney injury or renal failure
EP2350669B9 (en) * 2008-10-31 2014-06-11 St Vincent's Hospital Sydney Limited Methods of prognosis in chronic kidney disease
EP3246708A3 (en) * 2009-12-18 2018-01-03 Roche Diagnostics GmbH Troponins for predicting kidney failure in heart surgery patients
ES2818138T3 (es) * 2009-12-20 2021-04-09 Astute Medical Inc Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal

Also Published As

Publication number Publication date
US20140315752A1 (en) 2014-10-23
US20170336421A1 (en) 2017-11-23
EP2783213A4 (en) 2015-09-09
AU2012340748A1 (en) 2014-06-26
EP2783213B1 (en) 2017-09-13
WO2013078253A1 (en) 2013-05-30
EP3282257A1 (en) 2018-02-14
NZ625725A (en) 2016-09-30
CA2856399A1 (en) 2013-05-30
EP2783213A1 (en) 2014-10-01

Similar Documents

Publication Publication Date Title
IN2014MN00949A (ja)
MX366653B (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
MX2011004767A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
NZ599105A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ592552A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
MX2011008323A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE554389T1 (de) Apex als marker für lungenkrebs
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2585826A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2012094658A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
FR2919061B1 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
MX2012003168A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
IN2014MN01759A (ja)
NZ703055A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure